Navigation Links
Public access mandate made law
Date:12/26/2007

President Bush has signed into law the Consolidated Appropriations Act of 2007 (H.R. 2764), which includes a provision directing the National Institutes of Health (NIH) to provide the public with open online access to findings from its funded research. This is the first time the U.S. government has mandated public access to research funded by a major agency.

The provision directs the NIH to change its existing Public Access Policy, implemented as a voluntary measure in 2005, so that participation is required for agency-funded investigators. Researchers will now be required to deposit electronic copies of their peer-reviewed manuscripts into the National Library of Medicines online archive, PubMed Central. Full texts of the articles will be publicly available and searchable online in PubMed Central no later than 12 months after publication in a journal.

"Facilitated access to new knowledge is key to the rapid advancement of science," said Harold Varmus, president of the Memorial Sloan-Kettering Cancer Center and Nobel Prize Winner. "The tremendous benefits of broad, unfettered access to information are already clear from the Human Genome Project, which has made its DNA sequences immediately and freely available to all via the Internet. Providing widespread access, even with a one-year delay, to the full text of research articles supported by funds from all institutes at the NIH will increase those benefits dramatically."

"Public access to publicly funded research contributes directly to the mission of higher education, said David Shulenburger, Vice President for Academic Affairs at NASULGC (the National Association of State Universities and Land-Grant Colleges). Improved access will enable universities to maximize their own investment in research, and widen the potential for discovery as the results are more readily available for others to build upon.

Years of unrelenting commitment and dedication by patient groups and our all
'/>"/>

Contact: Jennifer McLennan
jennifer@arl.org
202-296-2296 x121
SPARC
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Mailman School of Public Health study examines link between racial discrimination and substance use
2. New Poll Shows Public Distrusts Flawed Healthcare Approach Favored by Governor and Speaker in AB 8
3. Physician Skin Care Specialist Says Proposed New Rules for Sunscreen Products Will Better Protect the Public
4. Open access to health research publications
5. MultiVu Video Feed: PUBLIC HEALTH EXPERTS CONVENE TO DISCUSS THE TREATMENT AND PREVENTION OF RABIES
6. PA Secretary of Public Welfare Responds to Warren State Hospital Closure Rumors
7. Weiner Public News First Media Team at National Press Club 5K
8. ComPsych(R) Corp. Announces Health at Work(SM) Award Winners: Sprint, Erie Insurance, City of Naperville and Green Hills Public Library
9. Exelixis Commences Public Offering of Common Stock
10. PA Department of Public Welfare Begins Outreach to Medical Assistance Consumers Following Burglary at State Office Building
11. Public Health and Need for Consistent Standards Preclude Exception for Breastfeeding Mother in National Medical Licensing Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...be held on January 8, 2009 , , TORONTO, Nov...nal Inc. ("MedEmerg") (OTCBB: MDER), one of Canada... today that it has obtained an interim order from ...ts previously announced plan of arrangement (the "...nc. ("AIM") will acquire all of MedEmerg,s outstan...
(Date:11/21/2008)...ty of Texas Health Science Center at Houston will ... Studies (TEXAS), to promote geriatrics training f...rd from the Donald W. Reynolds Foundation and $1.2... to teach geriatric medicine principles to everyon...ng physicians. With the reach of Lyndon B. Johnson...
(Date:11/21/2008)...e-FirstCall/ -- Heska Corporation,(Nasdaq: HSKA... Society of,Security Analysts, 12th Annual Biotec...2008 at 1177 Avenue of the Americas, 2nd Floor in ...gin at 9:35 a.m. Eastern Time (7:35 a.m.,Mountain...for two weeks,following the presentation through ...
(Date:11/21/2008)...-USNewswire/ -- The Generic,Pharmaceutical Associ...y from,GPhA President and CEO Kathleen Jaeger reg...ble on "Emerging Health Care Competition and Consu...is conducting this roundtable demonstrates the,gr... access to safe and,affordable biogenerics sooner...
Breaking Medicine News(10 mins):Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 2Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 2Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 4Health News:GPhA Statement on FTC Roundtable on Biogenerics 2
...done in Greece to show the relationship of the pla...some interesting results.// The study took into co...plains and those living in the hills, data taken i... years, especially concerned with coronary disease...
...nity may lead you to blindness. According to a new...//scientists had been able to find out a genetic c...h of what is commonly known as blindness due to ag... that may cause macular degeneration in elderly pe...
...been successful in developing a computer aided ale...is in patients. //There had not been much attempts...t innovation is one of the first of its kind. The ...tion may be able to reduce the frequency of the co...
... that the drug Rimonabant (Acomplia) a selective ... patients keep weight off // . Supplementation wit...significant decrease in body weight and waist circ...us visceral fat. It also improved HDL (good) chole...
Other Medicine News:
(Date:11/20/2008)... RESULTS OF FIRST PHASE III TRIAL SHOW SIGNIFICANT...ENT IN DAILY FUNCTION, IN, ...., and BRUSSELS, Belgium, Nov. 20 /PRNewswire-Firs...AZZ ) and UCB (Euronext Brussels: UCB),announced ...he first of two,Phase III pivotal clinical trials...
(Date:11/20/2008)...0 Duska Therapeutics,I...hat it has submitted its,pivotal Phase 3 ATPace c...,Protocol Assessment (SPA) procedure with the U.S....ject to securing an agreement with the FDA, Duska ...-blind, placebo-controlled and randomized Phase 3,...
(Date:11/20/2008)...mber 20 The Scandinavian-based dru...ed results of studies on its,lead antimicrobial c..., DC,the studies showed that the novel lytic pep...ct, significantly better towards killing Staphyloc...eted gold standard drugs. In,addition to this it ...
(Date:11/19/2008)...rt basic findings on critical enzyme,s regulation ...an array of disorders , , MEMPHIS, Tenn., N...t. Jude Children,s Research Hospital have gained n...nzyme workhorses called calpains. , , As t...on in many cellular processes, including the movem...
Breaking Medicine Technology:Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 2Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 3Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 4Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 5Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 6Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4Lytix Presents LTX-109 Anti-Microbial Data at ICAAC 2New Insight Into the Controls on a Go-To Enzyme 2New Insight Into the Controls on a Go-To Enzyme 3Buyer of Bayonne Hospital to Pay U S 242 5 Million to Resolve Allegations of Medicare Fraud 10950 1Buyer of Bayonne Hospital to Pay U S 242 5 Million to Resolve Allegations of Medicare Fraud 10950 2Public Health Woefully Underfunded in Administrations Proposed Budget 10948 1Public Health Woefully Underfunded in Administrations Proposed Budget 10948 2Public Health Woefully Underfunded in Administrations Proposed Budget 10948 3Organ Donor Shortage Remains Obstacle for Would Be Transplant Patients Despite Better Medicine 1312 1Organ Donor Shortage Remains Obstacle for Would Be Transplant Patients Despite Better Medicine 1312 2Formerly Conjoined Twins Leave Packard Childrens Hospital 3B Heading Home to Costa Rica 10945 1Formerly Conjoined Twins Leave Packard Childrens Hospital 3B Heading Home to Costa Rica 10945 2
Used for contralateral access to the iliac artery for interventional procedures after initial wire guide positioning has been established.,NOTE: Use of a heavy-duty wire guide is recommended.
Sheath Introducers with guidewires.
The Driver Stent design, utilizing an advanced cobalt-based alloy, surpasses the limitations of stainless steel stents. This stronger alloy makes possible thinner struts, for unparalleled flexibility
The complete performance package. Precision handling. Stable platform for device delivery. Enhanced backup support. Unique braid technology. Improved curve retention. Smooth PTFE liner.
Medicine Products: